Gene Therapies for Hemophilia: Promising But There’s Room for Improvement, Say Reviewers
May 22nd 2023How long the gene therapies for hemophilia will keep factor levels high is unclear, said the authors of a review in the Annual Review of Medicine. Patients also need to be counseled that they can receive only one adeno-associated viral (AAV) vector in their lifetime.
Read More
Academic Institutions Hold Key to Gene Therapy Price Reduction, Say Academic Experts
May 22nd 2023Nonexclusive licensing of discoveries made at academic institutions would work to lower prices, say the writers of a recent opinion piece published in the New England Journal of Medicine. CMS price negotiation under the Inflation Reduction Act will not have any immediate effect on gene therapy prices and may never have.
Read More
Gene Therapy for Hemophilia Is Becoming a Reality. Who Will Write the Checks to Pay for It?
March 27th 2023Hemgenix for hemophilia B is priced to cost $3.5 million per treatment. Roctavian for hemophilia A may be approved by the FDA in July and is likely to be priced to cost between $2 million and $3 million per treatment.
Read More
Vaccine Development: Turning Marathons in to 100-day Dashes
February 24th 2023It took less than a year to develop the first COVID-19 vaccine, but an epidemic preparation group has said even more speed could be added and proposed setting 100 days as a goal for the development of future vaccines,
Read More
Well-Administered Coumadin No Worse for Mental Function Than Pradaxa, Study Finds
December 14th 2022Pradaxa (dabigatran) and Coumadin (warfarin) came out even in this randomized study. The Brazilian researchers who conducted the study said one explanation for the result is that use of Coumadin was exceptionally well managed because the patients were enrolled a study.
Read More
Some Mental Health Conditions Add to the Atrial Fibrillation Risk from Diabetes, Study Finds
December 9th 2022Korean study shows that depression, insomnia and anxiety add to the risk of atrial fibrillation among those with diabetes, according to a Korean study. Those mental health condition may affect the autonomic nervous system that regulates the heart. Bipolar disorder and schizophrenia did not increase the risk.
Read More
Weighing Ablation Options in Persistent, Large Atrium AF
November 14th 2022Researchers compared radiofrequency ablation, cryoballoon ablation and the thoracoscopic maze procedure. After adjustments for age and left atrium diameter, they found no prognostic differences among the treatment strategies for atrial fibrillation.
Read More
Investigators Report High Similarity Between NovoLog and Biosimilar Candidate
October 20th 2022A phase 3 trial sponsored by the biosimilar maker shows that its candidate, temporarily named MYL-1601D, has the same immunogenicity, efficacy and safety levels as NovoLog, Novo Nordisk’s brand-name insulin aspart. Novolog and its authorized generic currently have the U.S. insulin aspart market to themselves.
Read More
Study Provides Some Clues on How Smoking Might Lead to Atrial Fibrillation
October 17th 2022In mouse and other studies, University of South Florida researchers traced the effects of cigarette smoke on cardiac acetylcholine-activated inward rectifier potassium current, known as the heart’s 'pacemaker.'
Read More